Moreover, studies have found that the expression levels of FNIP1 in patients with cardiovascular diseases are closely linked to treatment outcomes (De Conti et al., 2015; Ren et al., 2021), potentially making FNIP1 an important marker for evaluating the effectiveness of cardiovascular disease treatments and guiding personalized therapy. This evidence concerns the gene FNIP1 and cardiovascular disorder.